Ophthalmology Times Newsletter

To view this email as a web page, click here.

Budding technology could be an OCT analysis game-changer

Tools for higher-order OCT assessment enable evaluation of features of interest, such as targeted retinal layers or fluid compartments, and may allow for unique characterization of disease phenotypes and treatment response.

Find out

Weigh risk, benefits of cataract surgery for your patients

Doug Katsev, MD, takes a look at two key factors for patients suffering from vision loss who are also considering undergoing cataract surgery, including the association with age-related macular degeneration (AMD).

Learn more

Teleglaucoma lets patients be more engaged in care

New technology for taking the evaluation, diagnosis, and management of glaucoma out of the clinic and directly to the patient is influencing not only community outreach efforts but the feasibility of using teleglaucoma tools in the home.

Read on

See who is attending OIS@AAO

View the impressive list of delegates already signed up to attend OIS@AAO on October 10th in San Francisco. If you aren’t already on the list, be sure to register:

https://ois.net/ois-aao-2019/oisaao-2019-attendees/

Safety key for intracamerally injected mydriatic agents in cataract surgery

Understand the expanding role of IPL in dry eye disease

These 3 things are part of a cataract surgeon’s signature

10 effective habits of a cataract surgeon

Quieting the neuropathic components of ocular pain

Pearls to manage cataract surgery on hypotonous eyes

Pushing the boundaries with monofocal toric IOL

Unleash the Power of your Optical.

We’ll help you reach the untapped potential within your dispensary. Imagine if your optical performed as well as your practice? Now it can. Vision, the largest optical dispensary management and consulting firm in the country can help!

www.visassoc.com. AAO Booth #5048

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.